Global Cardiac Biomarker POCT Immunodiagnostic Platform Supply, Demand and Key Producers, 2026-2032
The global Cardiac Biomarker POCT Immunodiagnostic Platform market size is expected to reach $ 380 million by 2032, rising at a market growth of 6.2% CAGR during the forecast period (2026-2032).
The Cardiac Biomarker POCT Immunodiagnostic Platform is a near-patient rapid immunodiagnostic system deployed in emergency departments, chest pain centers, intensive care units, cardiology outpatient clinics, primary care settings, and pre-hospital emergency care. It employs fluorescence immunoassay, chemiluminescence, or microfluidic technologies to measure cardiac injury biomarkers (such as cTnI, hs-cTnI, cTnT, CK-MB, myoglobin) and heart failure biomarkers (BNP, NT-proBNP). Upstream raw materials include high-specificity monoclonal antibodies, fluorescent or chemiluminescent labels, microfluidic chips, and dedicated consumables. The main downstream customers are hospitals? emergency departments, chest pain centers, cardiology clinics, primary care facilities, and pre-hospital emergency services worldwide. In 2025, global production capacity is approximately 26,500 units, with actual sales around 21,380 units, an average ex-factory price of 11,200 USD per unit, and an industry gross margin of 38%?50%.
The global market for cardiac biomarker POCT immunodiagnostic platforms exhibits a well-established competitive structure, with high-end companies in North America, Europe, and Japan coexisting with mid-tier manufacturers from China and South Korea. Clinical demand from emergency departments, chest pain centers, and intensive care units drives the adoption of platform-based solutions, while primary care and pre-hospital emergency settings gradually expand usage. Platforms have evolved from single cardiac marker tests to high-sensitivity troponin, multi-marker assays, microfluidic, and fluorescence immunoassay technologies, creating a full commercial ecosystem from devices to consumables. Market participants leverage analyzer and reagent binding, hospital data integration, and workflow coordination to establish competitive barriers, ensuring sustainable revenue and client retention.
Future development trends emphasize platform-based, multi-marker testing as the industry core, with high-sensitivity troponin and heart failure markers expanding penetration. Emerging technologies such as microfluidic chips, dry fluorescence assays, and automated operation systems improve detection speed, accuracy, and clinical applicability. Integration with hospital information systems and data management will become critical differentiators, supporting clinical decision-making, workflow integration, and remote monitoring. Regionally, Chinese and Korean manufacturers expand rapidly in mid-tier and export markets, while North American, European, and Japanese companies maintain dominance in high-end hospital segments, forming a multi-layered global competitive landscape.
Market growth is primarily driven by the clinical need for rapid, accurate, and short-turnaround diagnostics. High-sensitivity assays and multi-marker analysis optimize myocardial infarction triage and heart failure management, increasing clinical efficiency. Technology upgrades and product iterations provide opportunities for market share expansion and margin improvement. Downstream customers include hospitals, emergency departments, chest pain centers, ICUs, cardiology outpatient clinics, primary care facilities, and pre-hospital emergency services, with ongoing revenue supported by platform-consumable binding and client relationship management.
Market obstacles include stringent regulatory and clinical validation requirements, hospital procurement and reimbursement pacing, and the risk that low-sensitivity or single-marker platforms will be replaced by high-sensitivity, multi-marker, automated platforms. Variations in regional policies, payment structures, and clinical adoption rates also affect global growth. A company?s investment and capability in R&D, marketing, and clinical support directly influence its competitive position, while technological innovation and service systems remain essential paths to overcome market barriers.
This report studies the global Cardiac Biomarker POCT Immunodiagnostic Platform production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cardiac Biomarker POCT Immunodiagnostic Platform and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cardiac Biomarker POCT Immunodiagnostic Platform that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cardiac Biomarker POCT Immunodiagnostic Platform total production and demand, 2021-2032, (Units)
Global Cardiac Biomarker POCT Immunodiagnostic Platform total production value, 2021-2032, (USD Million)
Global Cardiac Biomarker POCT Immunodiagnostic Platform production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Cardiac Biomarker POCT Immunodiagnostic Platform consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Cardiac Biomarker POCT Immunodiagnostic Platform domestic production, consumption, key domestic manufacturers and share
Global Cardiac Biomarker POCT Immunodiagnostic Platform production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Cardiac Biomarker POCT Immunodiagnostic Platform production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Cardiac Biomarker POCT Immunodiagnostic Platform production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Cardiac Biomarker POCT Immunodiagnostic Platform market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott Laboratories, QuidelOrtho Corporation, Radiometer Medical, Siemens Healthineers, PHC Holdings, Guangzhou Wondfo Biotech, Getein Biotech, Boditech Med, SD BIOSENSOR, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cardiac Biomarker POCT Immunodiagnostic Platform market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Cardiac Biomarker POCT Immunodiagnostic Platform Market, By Region:
1. How big is the global Cardiac Biomarker POCT Immunodiagnostic Platform market?
2. What is the demand of the global Cardiac Biomarker POCT Immunodiagnostic Platform market?
3. What is the year over year growth of the global Cardiac Biomarker POCT Immunodiagnostic Platform market?
4. What is the production and production value of the global Cardiac Biomarker POCT Immunodiagnostic Platform market?
5. Who are the key producers in the global Cardiac Biomarker POCT Immunodiagnostic Platform market?
6. What are the growth factors driving the market demand?
The Cardiac Biomarker POCT Immunodiagnostic Platform is a near-patient rapid immunodiagnostic system deployed in emergency departments, chest pain centers, intensive care units, cardiology outpatient clinics, primary care settings, and pre-hospital emergency care. It employs fluorescence immunoassay, chemiluminescence, or microfluidic technologies to measure cardiac injury biomarkers (such as cTnI, hs-cTnI, cTnT, CK-MB, myoglobin) and heart failure biomarkers (BNP, NT-proBNP). Upstream raw materials include high-specificity monoclonal antibodies, fluorescent or chemiluminescent labels, microfluidic chips, and dedicated consumables. The main downstream customers are hospitals? emergency departments, chest pain centers, cardiology clinics, primary care facilities, and pre-hospital emergency services worldwide. In 2025, global production capacity is approximately 26,500 units, with actual sales around 21,380 units, an average ex-factory price of 11,200 USD per unit, and an industry gross margin of 38%?50%.
The global market for cardiac biomarker POCT immunodiagnostic platforms exhibits a well-established competitive structure, with high-end companies in North America, Europe, and Japan coexisting with mid-tier manufacturers from China and South Korea. Clinical demand from emergency departments, chest pain centers, and intensive care units drives the adoption of platform-based solutions, while primary care and pre-hospital emergency settings gradually expand usage. Platforms have evolved from single cardiac marker tests to high-sensitivity troponin, multi-marker assays, microfluidic, and fluorescence immunoassay technologies, creating a full commercial ecosystem from devices to consumables. Market participants leverage analyzer and reagent binding, hospital data integration, and workflow coordination to establish competitive barriers, ensuring sustainable revenue and client retention.
Future development trends emphasize platform-based, multi-marker testing as the industry core, with high-sensitivity troponin and heart failure markers expanding penetration. Emerging technologies such as microfluidic chips, dry fluorescence assays, and automated operation systems improve detection speed, accuracy, and clinical applicability. Integration with hospital information systems and data management will become critical differentiators, supporting clinical decision-making, workflow integration, and remote monitoring. Regionally, Chinese and Korean manufacturers expand rapidly in mid-tier and export markets, while North American, European, and Japanese companies maintain dominance in high-end hospital segments, forming a multi-layered global competitive landscape.
Market growth is primarily driven by the clinical need for rapid, accurate, and short-turnaround diagnostics. High-sensitivity assays and multi-marker analysis optimize myocardial infarction triage and heart failure management, increasing clinical efficiency. Technology upgrades and product iterations provide opportunities for market share expansion and margin improvement. Downstream customers include hospitals, emergency departments, chest pain centers, ICUs, cardiology outpatient clinics, primary care facilities, and pre-hospital emergency services, with ongoing revenue supported by platform-consumable binding and client relationship management.
Market obstacles include stringent regulatory and clinical validation requirements, hospital procurement and reimbursement pacing, and the risk that low-sensitivity or single-marker platforms will be replaced by high-sensitivity, multi-marker, automated platforms. Variations in regional policies, payment structures, and clinical adoption rates also affect global growth. A company?s investment and capability in R&D, marketing, and clinical support directly influence its competitive position, while technological innovation and service systems remain essential paths to overcome market barriers.
This report studies the global Cardiac Biomarker POCT Immunodiagnostic Platform production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cardiac Biomarker POCT Immunodiagnostic Platform and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cardiac Biomarker POCT Immunodiagnostic Platform that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cardiac Biomarker POCT Immunodiagnostic Platform total production and demand, 2021-2032, (Units)
Global Cardiac Biomarker POCT Immunodiagnostic Platform total production value, 2021-2032, (USD Million)
Global Cardiac Biomarker POCT Immunodiagnostic Platform production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Cardiac Biomarker POCT Immunodiagnostic Platform consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Cardiac Biomarker POCT Immunodiagnostic Platform domestic production, consumption, key domestic manufacturers and share
Global Cardiac Biomarker POCT Immunodiagnostic Platform production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Cardiac Biomarker POCT Immunodiagnostic Platform production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Cardiac Biomarker POCT Immunodiagnostic Platform production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Cardiac Biomarker POCT Immunodiagnostic Platform market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott Laboratories, QuidelOrtho Corporation, Radiometer Medical, Siemens Healthineers, PHC Holdings, Guangzhou Wondfo Biotech, Getein Biotech, Boditech Med, SD BIOSENSOR, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cardiac Biomarker POCT Immunodiagnostic Platform market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Cardiac Biomarker POCT Immunodiagnostic Platform Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Fluorescence Immunoassay
- Chemiluminescence Immunoassay
- Other
- Handheld Platforms
- Compact Benchtop Platforms
- Other
- Troponin-focused Platforms
- Natriuretic Peptide-focused Platforms
- Other
- Hospital
- Clinic
- Others
- Roche
- Abbott Laboratories
- QuidelOrtho Corporation
- Radiometer Medical
- Siemens Healthineers
- PHC Holdings
- Guangzhou Wondfo Biotech
- Getein Biotech
- Boditech Med
- SD BIOSENSOR
- Lepu Medical Technology
- Humasis
- NanoEntek
- Xiamen Biotime Biotechnology
- Nanjing Lansion Biotechnology
- Shenzhen Micropoint Biotechnologies
- Shijiazhuang Hipro Biotechnology
- AEHEALTH
- Guangzhou KOFA Biotechnology
- Response Biomedical
1. How big is the global Cardiac Biomarker POCT Immunodiagnostic Platform market?
2. What is the demand of the global Cardiac Biomarker POCT Immunodiagnostic Platform market?
3. What is the year over year growth of the global Cardiac Biomarker POCT Immunodiagnostic Platform market?
4. What is the production and production value of the global Cardiac Biomarker POCT Immunodiagnostic Platform market?
5. Who are the key producers in the global Cardiac Biomarker POCT Immunodiagnostic Platform market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cardiac Biomarker POCT Immunodiagnostic Platform Introduction
1.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Supply & Forecast
1.2.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value (2021 & 2025 & 2032)
1.2.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032)
1.2.3 World Cardiac Biomarker POCT Immunodiagnostic Platform Pricing Trends (2021-2032)
1.3 World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Region (Based on Production Site)
1.3.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Region (2021-2032)
1.3.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Region (2021-2032)
1.3.3 World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Region (2021-2032)
1.3.4 North America Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032)
1.3.5 Europe Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032)
1.3.6 China Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032)
1.3.7 Japan Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cardiac Biomarker POCT Immunodiagnostic Platform Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cardiac Biomarker POCT Immunodiagnostic Platform Major Market Trends
2 DEMAND SUMMARY
2.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Demand (2021-2032)
2.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Consumption by Region
2.2.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Consumption by Region (2021-2026)
2.2.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Consumption Forecast by Region (2027-2032)
2.3 United States Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032)
2.4 China Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032)
2.5 Europe Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032)
2.6 Japan Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032)
2.7 South Korea Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032)
2.8 ASEAN Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032)
2.9 India Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Manufacturer (2021-2026)
3.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Manufacturer (2021-2026)
3.3 World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Manufacturer (2021-2026)
3.4 Cardiac Biomarker POCT Immunodiagnostic Platform Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Cardiac Biomarker POCT Immunodiagnostic Platform Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Cardiac Biomarker POCT Immunodiagnostic Platform in 2025
3.5.3 Global Concentration Ratios (CR8) for Cardiac Biomarker POCT Immunodiagnostic Platform in 2025
3.6 Cardiac Biomarker POCT Immunodiagnostic Platform Market: Overall Company Footprint Analysis
3.6.1 Cardiac Biomarker POCT Immunodiagnostic Platform Market: Region Footprint
3.6.2 Cardiac Biomarker POCT Immunodiagnostic Platform Market: Company Product Type Footprint
3.6.3 Cardiac Biomarker POCT Immunodiagnostic Platform Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Comparison
4.1.1 United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Production Comparison
4.2.1 United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Consumption Comparison
4.3.1 United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Cardiac Biomarker POCT Immunodiagnostic Platform Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Cardiac Biomarker POCT Immunodiagnostic Platform Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Value (2021-2026)
4.4.3 United States Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2026)
4.5 China Based Cardiac Biomarker POCT Immunodiagnostic Platform Manufacturers and Market Share
4.5.1 China Based Cardiac Biomarker POCT Immunodiagnostic Platform Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Value (2021-2026)
4.5.3 China Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2026)
4.6 Rest of World Based Cardiac Biomarker POCT Immunodiagnostic Platform Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Cardiac Biomarker POCT Immunodiagnostic Platform Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Fluorescence Immunoassay
5.2.2 Chemiluminescence Immunoassay
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Type (2021-2032)
5.3.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Type (2021-2032)
5.3.3 World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PLATFORM FORM
6.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Market Size Overview by Platform Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Platform Form
6.2.1 Handheld Platforms
6.2.2 Compact Benchtop Platforms
6.2.3 Other
6.3 Market Segment by Platform Form
6.3.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Platform Form (2021-2032)
6.3.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Platform Form (2021-2032)
6.3.3 World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Platform Form (2021-2032)
7 MARKET ANALYSIS BY CARDIAC BIOMARKER
7.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Market Size Overview by Cardiac Biomarker: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Cardiac Biomarker
7.2.1 Troponin-focused Platforms
7.2.2 Natriuretic Peptide-focused Platforms
7.2.3 Other
7.3 Market Segment by Cardiac Biomarker
7.3.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Cardiac Biomarker (2021-2032)
7.3.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Cardiac Biomarker (2021-2032)
7.3.3 World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Cardiac Biomarker (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Application (2021-2032)
8.3.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Application (2021-2032)
8.3.3 World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Roche
9.1.1 Roche Details
9.1.2 Roche Major Business
9.1.3 Roche Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.1.4 Roche Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Roche Recent Developments/Updates
9.1.6 Roche Competitive Strengths & Weaknesses
9.2 Abbott Laboratories
9.2.1 Abbott Laboratories Details
9.2.2 Abbott Laboratories Major Business
9.2.3 Abbott Laboratories Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.2.4 Abbott Laboratories Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Abbott Laboratories Recent Developments/Updates
9.2.6 Abbott Laboratories Competitive Strengths & Weaknesses
9.3 QuidelOrtho Corporation
9.3.1 QuidelOrtho Corporation Details
9.3.2 QuidelOrtho Corporation Major Business
9.3.3 QuidelOrtho Corporation Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.3.4 QuidelOrtho Corporation Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 QuidelOrtho Corporation Recent Developments/Updates
9.3.6 QuidelOrtho Corporation Competitive Strengths & Weaknesses
9.4 Radiometer Medical
9.4.1 Radiometer Medical Details
9.4.2 Radiometer Medical Major Business
9.4.3 Radiometer Medical Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.4.4 Radiometer Medical Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Radiometer Medical Recent Developments/Updates
9.4.6 Radiometer Medical Competitive Strengths & Weaknesses
9.5 Siemens Healthineers
9.5.1 Siemens Healthineers Details
9.5.2 Siemens Healthineers Major Business
9.5.3 Siemens Healthineers Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.5.4 Siemens Healthineers Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Siemens Healthineers Recent Developments/Updates
9.5.6 Siemens Healthineers Competitive Strengths & Weaknesses
9.6 PHC Holdings
9.6.1 PHC Holdings Details
9.6.2 PHC Holdings Major Business
9.6.3 PHC Holdings Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.6.4 PHC Holdings Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 PHC Holdings Recent Developments/Updates
9.6.6 PHC Holdings Competitive Strengths & Weaknesses
9.7 Guangzhou Wondfo Biotech
9.7.1 Guangzhou Wondfo Biotech Details
9.7.2 Guangzhou Wondfo Biotech Major Business
9.7.3 Guangzhou Wondfo Biotech Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.7.4 Guangzhou Wondfo Biotech Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Guangzhou Wondfo Biotech Recent Developments/Updates
9.7.6 Guangzhou Wondfo Biotech Competitive Strengths & Weaknesses
9.8 Getein Biotech
9.8.1 Getein Biotech Details
9.8.2 Getein Biotech Major Business
9.8.3 Getein Biotech Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.8.4 Getein Biotech Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Getein Biotech Recent Developments/Updates
9.8.6 Getein Biotech Competitive Strengths & Weaknesses
9.9 Boditech Med
9.9.1 Boditech Med Details
9.9.2 Boditech Med Major Business
9.9.3 Boditech Med Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.9.4 Boditech Med Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Boditech Med Recent Developments/Updates
9.9.6 Boditech Med Competitive Strengths & Weaknesses
9.10 SD BIOSENSOR
9.10.1 SD BIOSENSOR Details
9.10.2 SD BIOSENSOR Major Business
9.10.3 SD BIOSENSOR Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.10.4 SD BIOSENSOR Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 SD BIOSENSOR Recent Developments/Updates
9.10.6 SD BIOSENSOR Competitive Strengths & Weaknesses
9.11 Lepu Medical Technology
9.11.1 Lepu Medical Technology Details
9.11.2 Lepu Medical Technology Major Business
9.11.3 Lepu Medical Technology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.11.4 Lepu Medical Technology Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Lepu Medical Technology Recent Developments/Updates
9.11.6 Lepu Medical Technology Competitive Strengths & Weaknesses
9.12 Humasis
9.12.1 Humasis Details
9.12.2 Humasis Major Business
9.12.3 Humasis Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.12.4 Humasis Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Humasis Recent Developments/Updates
9.12.6 Humasis Competitive Strengths & Weaknesses
9.13 NanoEntek
9.13.1 NanoEntek Details
9.13.2 NanoEntek Major Business
9.13.3 NanoEntek Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.13.4 NanoEntek Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 NanoEntek Recent Developments/Updates
9.13.6 NanoEntek Competitive Strengths & Weaknesses
9.14 Xiamen Biotime Biotechnology
9.14.1 Xiamen Biotime Biotechnology Details
9.14.2 Xiamen Biotime Biotechnology Major Business
9.14.3 Xiamen Biotime Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.14.4 Xiamen Biotime Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Xiamen Biotime Biotechnology Recent Developments/Updates
9.14.6 Xiamen Biotime Biotechnology Competitive Strengths & Weaknesses
9.15 Nanjing Lansion Biotechnology
9.15.1 Nanjing Lansion Biotechnology Details
9.15.2 Nanjing Lansion Biotechnology Major Business
9.15.3 Nanjing Lansion Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.15.4 Nanjing Lansion Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Nanjing Lansion Biotechnology Recent Developments/Updates
9.15.6 Nanjing Lansion Biotechnology Competitive Strengths & Weaknesses
9.16 Shenzhen Micropoint Biotechnologies
9.16.1 Shenzhen Micropoint Biotechnologies Details
9.16.2 Shenzhen Micropoint Biotechnologies Major Business
9.16.3 Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.16.4 Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Shenzhen Micropoint Biotechnologies Recent Developments/Updates
9.16.6 Shenzhen Micropoint Biotechnologies Competitive Strengths & Weaknesses
9.17 Shijiazhuang Hipro Biotechnology
9.17.1 Shijiazhuang Hipro Biotechnology Details
9.17.2 Shijiazhuang Hipro Biotechnology Major Business
9.17.3 Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.17.4 Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Shijiazhuang Hipro Biotechnology Recent Developments/Updates
9.17.6 Shijiazhuang Hipro Biotechnology Competitive Strengths & Weaknesses
9.18 AEHEALTH
9.18.1 AEHEALTH Details
9.18.2 AEHEALTH Major Business
9.18.3 AEHEALTH Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.18.4 AEHEALTH Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 AEHEALTH Recent Developments/Updates
9.18.6 AEHEALTH Competitive Strengths & Weaknesses
9.19 Guangzhou KOFA Biotechnology
9.19.1 Guangzhou KOFA Biotechnology Details
9.19.2 Guangzhou KOFA Biotechnology Major Business
9.19.3 Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.19.4 Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Guangzhou KOFA Biotechnology Recent Developments/Updates
9.19.6 Guangzhou KOFA Biotechnology Competitive Strengths & Weaknesses
9.20 Response Biomedical
9.20.1 Response Biomedical Details
9.20.2 Response Biomedical Major Business
9.20.3 Response Biomedical Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.20.4 Response Biomedical Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Response Biomedical Recent Developments/Updates
9.20.6 Response Biomedical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Cardiac Biomarker POCT Immunodiagnostic Platform Industry Chain
10.2 Cardiac Biomarker POCT Immunodiagnostic Platform Upstream Analysis
10.2.1 Cardiac Biomarker POCT Immunodiagnostic Platform Core Raw Materials
10.2.2 Main Manufacturers of Cardiac Biomarker POCT Immunodiagnostic Platform Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Cardiac Biomarker POCT Immunodiagnostic Platform Production Mode
10.6 Cardiac Biomarker POCT Immunodiagnostic Platform Procurement Model
10.7 Cardiac Biomarker POCT Immunodiagnostic Platform Industry Sales Model and Sales Channels
10.7.1 Cardiac Biomarker POCT Immunodiagnostic Platform Sales Model
10.7.2 Cardiac Biomarker POCT Immunodiagnostic Platform Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Cardiac Biomarker POCT Immunodiagnostic Platform Introduction
1.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Supply & Forecast
1.2.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value (2021 & 2025 & 2032)
1.2.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032)
1.2.3 World Cardiac Biomarker POCT Immunodiagnostic Platform Pricing Trends (2021-2032)
1.3 World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Region (Based on Production Site)
1.3.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Region (2021-2032)
1.3.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Region (2021-2032)
1.3.3 World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Region (2021-2032)
1.3.4 North America Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032)
1.3.5 Europe Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032)
1.3.6 China Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032)
1.3.7 Japan Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cardiac Biomarker POCT Immunodiagnostic Platform Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cardiac Biomarker POCT Immunodiagnostic Platform Major Market Trends
2 DEMAND SUMMARY
2.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Demand (2021-2032)
2.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Consumption by Region
2.2.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Consumption by Region (2021-2026)
2.2.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Consumption Forecast by Region (2027-2032)
2.3 United States Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032)
2.4 China Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032)
2.5 Europe Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032)
2.6 Japan Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032)
2.7 South Korea Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032)
2.8 ASEAN Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032)
2.9 India Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Manufacturer (2021-2026)
3.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Manufacturer (2021-2026)
3.3 World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Manufacturer (2021-2026)
3.4 Cardiac Biomarker POCT Immunodiagnostic Platform Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Cardiac Biomarker POCT Immunodiagnostic Platform Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Cardiac Biomarker POCT Immunodiagnostic Platform in 2025
3.5.3 Global Concentration Ratios (CR8) for Cardiac Biomarker POCT Immunodiagnostic Platform in 2025
3.6 Cardiac Biomarker POCT Immunodiagnostic Platform Market: Overall Company Footprint Analysis
3.6.1 Cardiac Biomarker POCT Immunodiagnostic Platform Market: Region Footprint
3.6.2 Cardiac Biomarker POCT Immunodiagnostic Platform Market: Company Product Type Footprint
3.6.3 Cardiac Biomarker POCT Immunodiagnostic Platform Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Comparison
4.1.1 United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Production Comparison
4.2.1 United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Consumption Comparison
4.3.1 United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Cardiac Biomarker POCT Immunodiagnostic Platform Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Cardiac Biomarker POCT Immunodiagnostic Platform Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Value (2021-2026)
4.4.3 United States Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2026)
4.5 China Based Cardiac Biomarker POCT Immunodiagnostic Platform Manufacturers and Market Share
4.5.1 China Based Cardiac Biomarker POCT Immunodiagnostic Platform Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Value (2021-2026)
4.5.3 China Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2026)
4.6 Rest of World Based Cardiac Biomarker POCT Immunodiagnostic Platform Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Cardiac Biomarker POCT Immunodiagnostic Platform Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Fluorescence Immunoassay
5.2.2 Chemiluminescence Immunoassay
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Type (2021-2032)
5.3.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Type (2021-2032)
5.3.3 World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PLATFORM FORM
6.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Market Size Overview by Platform Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Platform Form
6.2.1 Handheld Platforms
6.2.2 Compact Benchtop Platforms
6.2.3 Other
6.3 Market Segment by Platform Form
6.3.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Platform Form (2021-2032)
6.3.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Platform Form (2021-2032)
6.3.3 World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Platform Form (2021-2032)
7 MARKET ANALYSIS BY CARDIAC BIOMARKER
7.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Market Size Overview by Cardiac Biomarker: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Cardiac Biomarker
7.2.1 Troponin-focused Platforms
7.2.2 Natriuretic Peptide-focused Platforms
7.2.3 Other
7.3 Market Segment by Cardiac Biomarker
7.3.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Cardiac Biomarker (2021-2032)
7.3.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Cardiac Biomarker (2021-2032)
7.3.3 World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Cardiac Biomarker (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Application (2021-2032)
8.3.2 World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Application (2021-2032)
8.3.3 World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Roche
9.1.1 Roche Details
9.1.2 Roche Major Business
9.1.3 Roche Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.1.4 Roche Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Roche Recent Developments/Updates
9.1.6 Roche Competitive Strengths & Weaknesses
9.2 Abbott Laboratories
9.2.1 Abbott Laboratories Details
9.2.2 Abbott Laboratories Major Business
9.2.3 Abbott Laboratories Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.2.4 Abbott Laboratories Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Abbott Laboratories Recent Developments/Updates
9.2.6 Abbott Laboratories Competitive Strengths & Weaknesses
9.3 QuidelOrtho Corporation
9.3.1 QuidelOrtho Corporation Details
9.3.2 QuidelOrtho Corporation Major Business
9.3.3 QuidelOrtho Corporation Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.3.4 QuidelOrtho Corporation Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 QuidelOrtho Corporation Recent Developments/Updates
9.3.6 QuidelOrtho Corporation Competitive Strengths & Weaknesses
9.4 Radiometer Medical
9.4.1 Radiometer Medical Details
9.4.2 Radiometer Medical Major Business
9.4.3 Radiometer Medical Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.4.4 Radiometer Medical Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Radiometer Medical Recent Developments/Updates
9.4.6 Radiometer Medical Competitive Strengths & Weaknesses
9.5 Siemens Healthineers
9.5.1 Siemens Healthineers Details
9.5.2 Siemens Healthineers Major Business
9.5.3 Siemens Healthineers Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.5.4 Siemens Healthineers Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Siemens Healthineers Recent Developments/Updates
9.5.6 Siemens Healthineers Competitive Strengths & Weaknesses
9.6 PHC Holdings
9.6.1 PHC Holdings Details
9.6.2 PHC Holdings Major Business
9.6.3 PHC Holdings Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.6.4 PHC Holdings Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 PHC Holdings Recent Developments/Updates
9.6.6 PHC Holdings Competitive Strengths & Weaknesses
9.7 Guangzhou Wondfo Biotech
9.7.1 Guangzhou Wondfo Biotech Details
9.7.2 Guangzhou Wondfo Biotech Major Business
9.7.3 Guangzhou Wondfo Biotech Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.7.4 Guangzhou Wondfo Biotech Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Guangzhou Wondfo Biotech Recent Developments/Updates
9.7.6 Guangzhou Wondfo Biotech Competitive Strengths & Weaknesses
9.8 Getein Biotech
9.8.1 Getein Biotech Details
9.8.2 Getein Biotech Major Business
9.8.3 Getein Biotech Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.8.4 Getein Biotech Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Getein Biotech Recent Developments/Updates
9.8.6 Getein Biotech Competitive Strengths & Weaknesses
9.9 Boditech Med
9.9.1 Boditech Med Details
9.9.2 Boditech Med Major Business
9.9.3 Boditech Med Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.9.4 Boditech Med Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Boditech Med Recent Developments/Updates
9.9.6 Boditech Med Competitive Strengths & Weaknesses
9.10 SD BIOSENSOR
9.10.1 SD BIOSENSOR Details
9.10.2 SD BIOSENSOR Major Business
9.10.3 SD BIOSENSOR Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.10.4 SD BIOSENSOR Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 SD BIOSENSOR Recent Developments/Updates
9.10.6 SD BIOSENSOR Competitive Strengths & Weaknesses
9.11 Lepu Medical Technology
9.11.1 Lepu Medical Technology Details
9.11.2 Lepu Medical Technology Major Business
9.11.3 Lepu Medical Technology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.11.4 Lepu Medical Technology Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Lepu Medical Technology Recent Developments/Updates
9.11.6 Lepu Medical Technology Competitive Strengths & Weaknesses
9.12 Humasis
9.12.1 Humasis Details
9.12.2 Humasis Major Business
9.12.3 Humasis Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.12.4 Humasis Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Humasis Recent Developments/Updates
9.12.6 Humasis Competitive Strengths & Weaknesses
9.13 NanoEntek
9.13.1 NanoEntek Details
9.13.2 NanoEntek Major Business
9.13.3 NanoEntek Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.13.4 NanoEntek Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 NanoEntek Recent Developments/Updates
9.13.6 NanoEntek Competitive Strengths & Weaknesses
9.14 Xiamen Biotime Biotechnology
9.14.1 Xiamen Biotime Biotechnology Details
9.14.2 Xiamen Biotime Biotechnology Major Business
9.14.3 Xiamen Biotime Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.14.4 Xiamen Biotime Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Xiamen Biotime Biotechnology Recent Developments/Updates
9.14.6 Xiamen Biotime Biotechnology Competitive Strengths & Weaknesses
9.15 Nanjing Lansion Biotechnology
9.15.1 Nanjing Lansion Biotechnology Details
9.15.2 Nanjing Lansion Biotechnology Major Business
9.15.3 Nanjing Lansion Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.15.4 Nanjing Lansion Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Nanjing Lansion Biotechnology Recent Developments/Updates
9.15.6 Nanjing Lansion Biotechnology Competitive Strengths & Weaknesses
9.16 Shenzhen Micropoint Biotechnologies
9.16.1 Shenzhen Micropoint Biotechnologies Details
9.16.2 Shenzhen Micropoint Biotechnologies Major Business
9.16.3 Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.16.4 Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Shenzhen Micropoint Biotechnologies Recent Developments/Updates
9.16.6 Shenzhen Micropoint Biotechnologies Competitive Strengths & Weaknesses
9.17 Shijiazhuang Hipro Biotechnology
9.17.1 Shijiazhuang Hipro Biotechnology Details
9.17.2 Shijiazhuang Hipro Biotechnology Major Business
9.17.3 Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.17.4 Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Shijiazhuang Hipro Biotechnology Recent Developments/Updates
9.17.6 Shijiazhuang Hipro Biotechnology Competitive Strengths & Weaknesses
9.18 AEHEALTH
9.18.1 AEHEALTH Details
9.18.2 AEHEALTH Major Business
9.18.3 AEHEALTH Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.18.4 AEHEALTH Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 AEHEALTH Recent Developments/Updates
9.18.6 AEHEALTH Competitive Strengths & Weaknesses
9.19 Guangzhou KOFA Biotechnology
9.19.1 Guangzhou KOFA Biotechnology Details
9.19.2 Guangzhou KOFA Biotechnology Major Business
9.19.3 Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.19.4 Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Guangzhou KOFA Biotechnology Recent Developments/Updates
9.19.6 Guangzhou KOFA Biotechnology Competitive Strengths & Weaknesses
9.20 Response Biomedical
9.20.1 Response Biomedical Details
9.20.2 Response Biomedical Major Business
9.20.3 Response Biomedical Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
9.20.4 Response Biomedical Cardiac Biomarker POCT Immunodiagnostic Platform Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Response Biomedical Recent Developments/Updates
9.20.6 Response Biomedical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Cardiac Biomarker POCT Immunodiagnostic Platform Industry Chain
10.2 Cardiac Biomarker POCT Immunodiagnostic Platform Upstream Analysis
10.2.1 Cardiac Biomarker POCT Immunodiagnostic Platform Core Raw Materials
10.2.2 Main Manufacturers of Cardiac Biomarker POCT Immunodiagnostic Platform Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Cardiac Biomarker POCT Immunodiagnostic Platform Production Mode
10.6 Cardiac Biomarker POCT Immunodiagnostic Platform Procurement Model
10.7 Cardiac Biomarker POCT Immunodiagnostic Platform Industry Sales Model and Sales Channels
10.7.1 Cardiac Biomarker POCT Immunodiagnostic Platform Sales Model
10.7.2 Cardiac Biomarker POCT Immunodiagnostic Platform Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Region (2021-2026) & (USD Million)
Table 3. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Region (2027-2032) & (USD Million)
Table 4. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Region (2021-2026)
Table 5. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Region (2027-2032)
Table 6. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Region (2021-2026) & (Units)
Table 7. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Region (2027-2032) & (Units)
Table 8. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share by Region (2021-2026)
Table 9. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share by Region (2027-2032)
Table 10. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Cardiac Biomarker POCT Immunodiagnostic Platform Major Market Trends
Table 13. World Cardiac Biomarker POCT Immunodiagnostic Platform Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Cardiac Biomarker POCT Immunodiagnostic Platform Consumption by Region (2021-2026) & (Units)
Table 15. World Cardiac Biomarker POCT Immunodiagnostic Platform Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Cardiac Biomarker POCT Immunodiagnostic Platform Producers in 2025
Table 18. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Cardiac Biomarker POCT Immunodiagnostic Platform Producers in 2025
Table 20. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Cardiac Biomarker POCT Immunodiagnostic Platform Company Evaluation Quadrant
Table 22. World Cardiac Biomarker POCT Immunodiagnostic Platform Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Cardiac Biomarker POCT Immunodiagnostic Platform Production Site of Key Manufacturer
Table 24. Cardiac Biomarker POCT Immunodiagnostic Platform Market: Company Product Type Footprint
Table 25. Cardiac Biomarker POCT Immunodiagnostic Platform Market: Company Product Application Footprint
Table 26. Cardiac Biomarker POCT Immunodiagnostic Platform Competitive Factors
Table 27. Cardiac Biomarker POCT Immunodiagnostic Platform New Entrant and Capacity Expansion Plans
Table 28. Cardiac Biomarker POCT Immunodiagnostic Platform Mergers & Acquisitions Activity
Table 29. United States VS China Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Cardiac Biomarker POCT Immunodiagnostic Platform Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Cardiac Biomarker POCT Immunodiagnostic Platform Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Cardiac Biomarker POCT Immunodiagnostic Platform Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share (2021-2026)
Table 37. China Based Cardiac Biomarker POCT Immunodiagnostic Platform Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share (2021-2026)
Table 42. Rest of World Based Cardiac Biomarker POCT Immunodiagnostic Platform Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share (2021-2026)
Table 47. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Type (2021-2026) & (Units)
Table 49. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Type (2027-2032) & (Units)
Table 50. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Type (2021-2026) & (USD Million)
Table 51. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Type (2027-2032) & (USD Million)
Table 52. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Platform Form, (USD Million), 2021 & 2025 & 2032
Table 55. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Platform Form (2021-2026) & (Units)
Table 56. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Platform Form (2027-2032) & (Units)
Table 57. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Platform Form (2021-2026) & (USD Million)
Table 58. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Platform Form (2027-2032) & (USD Million)
Table 59. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Platform Form (2021-2026) & (US$/Unit)
Table 60. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Platform Form (2027-2032) & (US$/Unit)
Table 61. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Cardiac Biomarker, (USD Million), 2021 & 2025 & 2032
Table 62. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Cardiac Biomarker (2021-2026) & (Units)
Table 63. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Cardiac Biomarker (2027-2032) & (Units)
Table 64. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Cardiac Biomarker (2021-2026) & (USD Million)
Table 65. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Cardiac Biomarker (2027-2032) & (USD Million)
Table 66. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Cardiac Biomarker (2021-2026) & (US$/Unit)
Table 67. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Cardiac Biomarker (2027-2032) & (US$/Unit)
Table 68. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Application (2021-2026) & (Units)
Table 70. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Application (2027-2032) & (Units)
Table 71. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Application (2021-2026) & (USD Million)
Table 72. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Application (2027-2032) & (USD Million)
Table 73. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Roche Basic Information, Manufacturing Base and Competitors
Table 76. Roche Major Business
Table 77. Roche Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 78. Roche Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Roche Recent Developments/Updates
Table 80. Roche Competitive Strengths & Weaknesses
Table 81. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 82. Abbott Laboratories Major Business
Table 83. Abbott Laboratories Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 84. Abbott Laboratories Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Abbott Laboratories Recent Developments/Updates
Table 86. Abbott Laboratories Competitive Strengths & Weaknesses
Table 87. QuidelOrtho Corporation Basic Information, Manufacturing Base and Competitors
Table 88. QuidelOrtho Corporation Major Business
Table 89. QuidelOrtho Corporation Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 90. QuidelOrtho Corporation Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. QuidelOrtho Corporation Recent Developments/Updates
Table 92. QuidelOrtho Corporation Competitive Strengths & Weaknesses
Table 93. Radiometer Medical Basic Information, Manufacturing Base and Competitors
Table 94. Radiometer Medical Major Business
Table 95. Radiometer Medical Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 96. Radiometer Medical Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Radiometer Medical Recent Developments/Updates
Table 98. Radiometer Medical Competitive Strengths & Weaknesses
Table 99. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 100. Siemens Healthineers Major Business
Table 101. Siemens Healthineers Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 102. Siemens Healthineers Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Siemens Healthineers Recent Developments/Updates
Table 104. Siemens Healthineers Competitive Strengths & Weaknesses
Table 105. PHC Holdings Basic Information, Manufacturing Base and Competitors
Table 106. PHC Holdings Major Business
Table 107. PHC Holdings Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 108. PHC Holdings Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. PHC Holdings Recent Developments/Updates
Table 110. PHC Holdings Competitive Strengths & Weaknesses
Table 111. Guangzhou Wondfo Biotech Basic Information, Manufacturing Base and Competitors
Table 112. Guangzhou Wondfo Biotech Major Business
Table 113. Guangzhou Wondfo Biotech Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 114. Guangzhou Wondfo Biotech Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Guangzhou Wondfo Biotech Recent Developments/Updates
Table 116. Guangzhou Wondfo Biotech Competitive Strengths & Weaknesses
Table 117. Getein Biotech Basic Information, Manufacturing Base and Competitors
Table 118. Getein Biotech Major Business
Table 119. Getein Biotech Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 120. Getein Biotech Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Getein Biotech Recent Developments/Updates
Table 122. Getein Biotech Competitive Strengths & Weaknesses
Table 123. Boditech Med Basic Information, Manufacturing Base and Competitors
Table 124. Boditech Med Major Business
Table 125. Boditech Med Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 126. Boditech Med Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Boditech Med Recent Developments/Updates
Table 128. Boditech Med Competitive Strengths & Weaknesses
Table 129. SD BIOSENSOR Basic Information, Manufacturing Base and Competitors
Table 130. SD BIOSENSOR Major Business
Table 131. SD BIOSENSOR Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 132. SD BIOSENSOR Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. SD BIOSENSOR Recent Developments/Updates
Table 134. SD BIOSENSOR Competitive Strengths & Weaknesses
Table 135. Lepu Medical Technology Basic Information, Manufacturing Base and Competitors
Table 136. Lepu Medical Technology Major Business
Table 137. Lepu Medical Technology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 138. Lepu Medical Technology Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Lepu Medical Technology Recent Developments/Updates
Table 140. Lepu Medical Technology Competitive Strengths & Weaknesses
Table 141. Humasis Basic Information, Manufacturing Base and Competitors
Table 142. Humasis Major Business
Table 143. Humasis Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 144. Humasis Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Humasis Recent Developments/Updates
Table 146. Humasis Competitive Strengths & Weaknesses
Table 147. NanoEntek Basic Information, Manufacturing Base and Competitors
Table 148. NanoEntek Major Business
Table 149. NanoEntek Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 150. NanoEntek Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. NanoEntek Recent Developments/Updates
Table 152. NanoEntek Competitive Strengths & Weaknesses
Table 153. Xiamen Biotime Biotechnology Basic Information, Manufacturing Base and Competitors
Table 154. Xiamen Biotime Biotechnology Major Business
Table 155. Xiamen Biotime Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 156. Xiamen Biotime Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Xiamen Biotime Biotechnology Recent Developments/Updates
Table 158. Xiamen Biotime Biotechnology Competitive Strengths & Weaknesses
Table 159. Nanjing Lansion Biotechnology Basic Information, Manufacturing Base and Competitors
Table 160. Nanjing Lansion Biotechnology Major Business
Table 161. Nanjing Lansion Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 162. Nanjing Lansion Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Nanjing Lansion Biotechnology Recent Developments/Updates
Table 164. Nanjing Lansion Biotechnology Competitive Strengths & Weaknesses
Table 165. Shenzhen Micropoint Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 166. Shenzhen Micropoint Biotechnologies Major Business
Table 167. Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 168. Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Shenzhen Micropoint Biotechnologies Recent Developments/Updates
Table 170. Shenzhen Micropoint Biotechnologies Competitive Strengths & Weaknesses
Table 171. Shijiazhuang Hipro Biotechnology Basic Information, Manufacturing Base and Competitors
Table 172. Shijiazhuang Hipro Biotechnology Major Business
Table 173. Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 174. Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Shijiazhuang Hipro Biotechnology Recent Developments/Updates
Table 176. Shijiazhuang Hipro Biotechnology Competitive Strengths & Weaknesses
Table 177. AEHEALTH Basic Information, Manufacturing Base and Competitors
Table 178. AEHEALTH Major Business
Table 179. AEHEALTH Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 180. AEHEALTH Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. AEHEALTH Recent Developments/Updates
Table 182. AEHEALTH Competitive Strengths & Weaknesses
Table 183. Guangzhou KOFA Biotechnology Basic Information, Manufacturing Base and Competitors
Table 184. Guangzhou KOFA Biotechnology Major Business
Table 185. Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 186. Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Guangzhou KOFA Biotechnology Recent Developments/Updates
Table 188. Guangzhou KOFA Biotechnology Competitive Strengths & Weaknesses
Table 189. Response Biomedical Basic Information, Manufacturing Base and Competitors
Table 190. Response Biomedical Major Business
Table 191. Response Biomedical Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 192. Response Biomedical Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Response Biomedical Recent Developments/Updates
Table 194. Response Biomedical Competitive Strengths & Weaknesses
Table 195. Global Key Players of Cardiac Biomarker POCT Immunodiagnostic Platform Upstream (Raw Materials)
Table 196. Global Cardiac Biomarker POCT Immunodiagnostic Platform Typical Customers
Table 197. Cardiac Biomarker POCT Immunodiagnostic Platform Typical Distributors
Table 1. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Region (2021-2026) & (USD Million)
Table 3. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Region (2027-2032) & (USD Million)
Table 4. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Region (2021-2026)
Table 5. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Region (2027-2032)
Table 6. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Region (2021-2026) & (Units)
Table 7. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Region (2027-2032) & (Units)
Table 8. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share by Region (2021-2026)
Table 9. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share by Region (2027-2032)
Table 10. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Cardiac Biomarker POCT Immunodiagnostic Platform Major Market Trends
Table 13. World Cardiac Biomarker POCT Immunodiagnostic Platform Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Cardiac Biomarker POCT Immunodiagnostic Platform Consumption by Region (2021-2026) & (Units)
Table 15. World Cardiac Biomarker POCT Immunodiagnostic Platform Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Cardiac Biomarker POCT Immunodiagnostic Platform Producers in 2025
Table 18. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Cardiac Biomarker POCT Immunodiagnostic Platform Producers in 2025
Table 20. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Cardiac Biomarker POCT Immunodiagnostic Platform Company Evaluation Quadrant
Table 22. World Cardiac Biomarker POCT Immunodiagnostic Platform Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Cardiac Biomarker POCT Immunodiagnostic Platform Production Site of Key Manufacturer
Table 24. Cardiac Biomarker POCT Immunodiagnostic Platform Market: Company Product Type Footprint
Table 25. Cardiac Biomarker POCT Immunodiagnostic Platform Market: Company Product Application Footprint
Table 26. Cardiac Biomarker POCT Immunodiagnostic Platform Competitive Factors
Table 27. Cardiac Biomarker POCT Immunodiagnostic Platform New Entrant and Capacity Expansion Plans
Table 28. Cardiac Biomarker POCT Immunodiagnostic Platform Mergers & Acquisitions Activity
Table 29. United States VS China Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Cardiac Biomarker POCT Immunodiagnostic Platform Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Cardiac Biomarker POCT Immunodiagnostic Platform Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Cardiac Biomarker POCT Immunodiagnostic Platform Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share (2021-2026)
Table 37. China Based Cardiac Biomarker POCT Immunodiagnostic Platform Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share (2021-2026)
Table 42. Rest of World Based Cardiac Biomarker POCT Immunodiagnostic Platform Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share (2021-2026)
Table 47. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Type (2021-2026) & (Units)
Table 49. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Type (2027-2032) & (Units)
Table 50. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Type (2021-2026) & (USD Million)
Table 51. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Type (2027-2032) & (USD Million)
Table 52. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Platform Form, (USD Million), 2021 & 2025 & 2032
Table 55. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Platform Form (2021-2026) & (Units)
Table 56. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Platform Form (2027-2032) & (Units)
Table 57. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Platform Form (2021-2026) & (USD Million)
Table 58. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Platform Form (2027-2032) & (USD Million)
Table 59. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Platform Form (2021-2026) & (US$/Unit)
Table 60. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Platform Form (2027-2032) & (US$/Unit)
Table 61. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Cardiac Biomarker, (USD Million), 2021 & 2025 & 2032
Table 62. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Cardiac Biomarker (2021-2026) & (Units)
Table 63. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Cardiac Biomarker (2027-2032) & (Units)
Table 64. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Cardiac Biomarker (2021-2026) & (USD Million)
Table 65. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Cardiac Biomarker (2027-2032) & (USD Million)
Table 66. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Cardiac Biomarker (2021-2026) & (US$/Unit)
Table 67. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Cardiac Biomarker (2027-2032) & (US$/Unit)
Table 68. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Application (2021-2026) & (Units)
Table 70. World Cardiac Biomarker POCT Immunodiagnostic Platform Production by Application (2027-2032) & (Units)
Table 71. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Application (2021-2026) & (USD Million)
Table 72. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Application (2027-2032) & (USD Million)
Table 73. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Roche Basic Information, Manufacturing Base and Competitors
Table 76. Roche Major Business
Table 77. Roche Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 78. Roche Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Roche Recent Developments/Updates
Table 80. Roche Competitive Strengths & Weaknesses
Table 81. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 82. Abbott Laboratories Major Business
Table 83. Abbott Laboratories Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 84. Abbott Laboratories Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Abbott Laboratories Recent Developments/Updates
Table 86. Abbott Laboratories Competitive Strengths & Weaknesses
Table 87. QuidelOrtho Corporation Basic Information, Manufacturing Base and Competitors
Table 88. QuidelOrtho Corporation Major Business
Table 89. QuidelOrtho Corporation Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 90. QuidelOrtho Corporation Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. QuidelOrtho Corporation Recent Developments/Updates
Table 92. QuidelOrtho Corporation Competitive Strengths & Weaknesses
Table 93. Radiometer Medical Basic Information, Manufacturing Base and Competitors
Table 94. Radiometer Medical Major Business
Table 95. Radiometer Medical Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 96. Radiometer Medical Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Radiometer Medical Recent Developments/Updates
Table 98. Radiometer Medical Competitive Strengths & Weaknesses
Table 99. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 100. Siemens Healthineers Major Business
Table 101. Siemens Healthineers Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 102. Siemens Healthineers Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Siemens Healthineers Recent Developments/Updates
Table 104. Siemens Healthineers Competitive Strengths & Weaknesses
Table 105. PHC Holdings Basic Information, Manufacturing Base and Competitors
Table 106. PHC Holdings Major Business
Table 107. PHC Holdings Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 108. PHC Holdings Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. PHC Holdings Recent Developments/Updates
Table 110. PHC Holdings Competitive Strengths & Weaknesses
Table 111. Guangzhou Wondfo Biotech Basic Information, Manufacturing Base and Competitors
Table 112. Guangzhou Wondfo Biotech Major Business
Table 113. Guangzhou Wondfo Biotech Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 114. Guangzhou Wondfo Biotech Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Guangzhou Wondfo Biotech Recent Developments/Updates
Table 116. Guangzhou Wondfo Biotech Competitive Strengths & Weaknesses
Table 117. Getein Biotech Basic Information, Manufacturing Base and Competitors
Table 118. Getein Biotech Major Business
Table 119. Getein Biotech Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 120. Getein Biotech Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Getein Biotech Recent Developments/Updates
Table 122. Getein Biotech Competitive Strengths & Weaknesses
Table 123. Boditech Med Basic Information, Manufacturing Base and Competitors
Table 124. Boditech Med Major Business
Table 125. Boditech Med Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 126. Boditech Med Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Boditech Med Recent Developments/Updates
Table 128. Boditech Med Competitive Strengths & Weaknesses
Table 129. SD BIOSENSOR Basic Information, Manufacturing Base and Competitors
Table 130. SD BIOSENSOR Major Business
Table 131. SD BIOSENSOR Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 132. SD BIOSENSOR Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. SD BIOSENSOR Recent Developments/Updates
Table 134. SD BIOSENSOR Competitive Strengths & Weaknesses
Table 135. Lepu Medical Technology Basic Information, Manufacturing Base and Competitors
Table 136. Lepu Medical Technology Major Business
Table 137. Lepu Medical Technology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 138. Lepu Medical Technology Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Lepu Medical Technology Recent Developments/Updates
Table 140. Lepu Medical Technology Competitive Strengths & Weaknesses
Table 141. Humasis Basic Information, Manufacturing Base and Competitors
Table 142. Humasis Major Business
Table 143. Humasis Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 144. Humasis Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Humasis Recent Developments/Updates
Table 146. Humasis Competitive Strengths & Weaknesses
Table 147. NanoEntek Basic Information, Manufacturing Base and Competitors
Table 148. NanoEntek Major Business
Table 149. NanoEntek Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 150. NanoEntek Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. NanoEntek Recent Developments/Updates
Table 152. NanoEntek Competitive Strengths & Weaknesses
Table 153. Xiamen Biotime Biotechnology Basic Information, Manufacturing Base and Competitors
Table 154. Xiamen Biotime Biotechnology Major Business
Table 155. Xiamen Biotime Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 156. Xiamen Biotime Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Xiamen Biotime Biotechnology Recent Developments/Updates
Table 158. Xiamen Biotime Biotechnology Competitive Strengths & Weaknesses
Table 159. Nanjing Lansion Biotechnology Basic Information, Manufacturing Base and Competitors
Table 160. Nanjing Lansion Biotechnology Major Business
Table 161. Nanjing Lansion Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 162. Nanjing Lansion Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Nanjing Lansion Biotechnology Recent Developments/Updates
Table 164. Nanjing Lansion Biotechnology Competitive Strengths & Weaknesses
Table 165. Shenzhen Micropoint Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 166. Shenzhen Micropoint Biotechnologies Major Business
Table 167. Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 168. Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Shenzhen Micropoint Biotechnologies Recent Developments/Updates
Table 170. Shenzhen Micropoint Biotechnologies Competitive Strengths & Weaknesses
Table 171. Shijiazhuang Hipro Biotechnology Basic Information, Manufacturing Base and Competitors
Table 172. Shijiazhuang Hipro Biotechnology Major Business
Table 173. Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 174. Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Shijiazhuang Hipro Biotechnology Recent Developments/Updates
Table 176. Shijiazhuang Hipro Biotechnology Competitive Strengths & Weaknesses
Table 177. AEHEALTH Basic Information, Manufacturing Base and Competitors
Table 178. AEHEALTH Major Business
Table 179. AEHEALTH Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 180. AEHEALTH Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. AEHEALTH Recent Developments/Updates
Table 182. AEHEALTH Competitive Strengths & Weaknesses
Table 183. Guangzhou KOFA Biotechnology Basic Information, Manufacturing Base and Competitors
Table 184. Guangzhou KOFA Biotechnology Major Business
Table 185. Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 186. Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Guangzhou KOFA Biotechnology Recent Developments/Updates
Table 188. Guangzhou KOFA Biotechnology Competitive Strengths & Weaknesses
Table 189. Response Biomedical Basic Information, Manufacturing Base and Competitors
Table 190. Response Biomedical Major Business
Table 191. Response Biomedical Cardiac Biomarker POCT Immunodiagnostic Platform Product and Services
Table 192. Response Biomedical Cardiac Biomarker POCT Immunodiagnostic Platform Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Response Biomedical Recent Developments/Updates
Table 194. Response Biomedical Competitive Strengths & Weaknesses
Table 195. Global Key Players of Cardiac Biomarker POCT Immunodiagnostic Platform Upstream (Raw Materials)
Table 196. Global Cardiac Biomarker POCT Immunodiagnostic Platform Typical Customers
Table 197. Cardiac Biomarker POCT Immunodiagnostic Platform Typical Distributors
LIST OF FIGURES
Figure 1. Cardiac Biomarker POCT Immunodiagnostic Platform Picture
Figure 2. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032) & (Units)
Figure 5. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price (2021-2032) & (US$/Unit)
Figure 6. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Region (2021-2032)
Figure 7. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share by Region (2021-2032)
Figure 8. North America Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032) & (Units)
Figure 9. Europe Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032) & (Units)
Figure 10. China Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032) & (Units)
Figure 11. Japan Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032) & (Units)
Figure 12. Cardiac Biomarker POCT Immunodiagnostic Platform Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032) & (Units)
Figure 15. World Cardiac Biomarker POCT Immunodiagnostic Platform Consumption Market Share by Region (2021-2032)
Figure 16. United States Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032) & (Units)
Figure 17. China Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032) & (Units)
Figure 18. Europe Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032) & (Units)
Figure 19. Japan Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032) & (Units)
Figure 20. South Korea Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032) & (Units)
Figure 21. ASEAN Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032) & (Units)
Figure 22. India Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032) & (Units)
Figure 23. Producer Shipments of Cardiac Biomarker POCT Immunodiagnostic Platform by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Cardiac Biomarker POCT Immunodiagnostic Platform Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Cardiac Biomarker POCT Immunodiagnostic Platform Markets in 2025
Figure 26. United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share 2025
Figure 30. China Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share 2025
Figure 32. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Type in 2025
Figure 34. Fluorescence Immunoassay
Figure 35. Chemiluminescence Immunoassay
Figure 36. Other
Figure 37. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share by Type (2021-2032)
Figure 38. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Type (2021-2032)
Figure 39. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Platform Form, (USD Million), 2021 & 2025 & 2032
Figure 41. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Platform Form in 2025
Figure 42. Handheld Platforms
Figure 43. Compact Benchtop Platforms
Figure 44. Other
Figure 45. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share by Platform Form (2021-2032)
Figure 46. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Platform Form (2021-2032)
Figure 47. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Platform Form (2021-2032) & (US$/Unit)
Figure 48. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Cardiac Biomarker, (USD Million), 2021 & 2025 & 2032
Figure 49. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Cardiac Biomarker in 2025
Figure 50. Troponin-focused Platforms
Figure 51. Natriuretic Peptide-focused Platforms
Figure 52. Other
Figure 53. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share by Cardiac Biomarker (2021-2032)
Figure 54. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Cardiac Biomarker (2021-2032)
Figure 55. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Cardiac Biomarker (2021-2032) & (US$/Unit)
Figure 56. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Application in 2025
Figure 58. Hospital
Figure 59. Clinic
Figure 60. Others
Figure 61. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share by Application (2021-2032)
Figure 62. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Application (2021-2032)
Figure 63. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Application (2021-2032) & (US$/Unit)
Figure 64. Cardiac Biomarker POCT Immunodiagnostic Platform Industry Chain
Figure 65. Cardiac Biomarker POCT Immunodiagnostic Platform Procurement Model
Figure 66. Cardiac Biomarker POCT Immunodiagnostic Platform Sales Model
Figure 67. Cardiac Biomarker POCT Immunodiagnostic Platform Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
Figure 1. Cardiac Biomarker POCT Immunodiagnostic Platform Picture
Figure 2. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032) & (Units)
Figure 5. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price (2021-2032) & (US$/Unit)
Figure 6. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Region (2021-2032)
Figure 7. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share by Region (2021-2032)
Figure 8. North America Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032) & (Units)
Figure 9. Europe Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032) & (Units)
Figure 10. China Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032) & (Units)
Figure 11. Japan Cardiac Biomarker POCT Immunodiagnostic Platform Production (2021-2032) & (Units)
Figure 12. Cardiac Biomarker POCT Immunodiagnostic Platform Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032) & (Units)
Figure 15. World Cardiac Biomarker POCT Immunodiagnostic Platform Consumption Market Share by Region (2021-2032)
Figure 16. United States Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032) & (Units)
Figure 17. China Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032) & (Units)
Figure 18. Europe Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032) & (Units)
Figure 19. Japan Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032) & (Units)
Figure 20. South Korea Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032) & (Units)
Figure 21. ASEAN Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032) & (Units)
Figure 22. India Cardiac Biomarker POCT Immunodiagnostic Platform Consumption (2021-2032) & (Units)
Figure 23. Producer Shipments of Cardiac Biomarker POCT Immunodiagnostic Platform by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Cardiac Biomarker POCT Immunodiagnostic Platform Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Cardiac Biomarker POCT Immunodiagnostic Platform Markets in 2025
Figure 26. United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Cardiac Biomarker POCT Immunodiagnostic Platform Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share 2025
Figure 30. China Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share 2025
Figure 32. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Type in 2025
Figure 34. Fluorescence Immunoassay
Figure 35. Chemiluminescence Immunoassay
Figure 36. Other
Figure 37. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share by Type (2021-2032)
Figure 38. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Type (2021-2032)
Figure 39. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Platform Form, (USD Million), 2021 & 2025 & 2032
Figure 41. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Platform Form in 2025
Figure 42. Handheld Platforms
Figure 43. Compact Benchtop Platforms
Figure 44. Other
Figure 45. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share by Platform Form (2021-2032)
Figure 46. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Platform Form (2021-2032)
Figure 47. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Platform Form (2021-2032) & (US$/Unit)
Figure 48. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Cardiac Biomarker, (USD Million), 2021 & 2025 & 2032
Figure 49. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Cardiac Biomarker in 2025
Figure 50. Troponin-focused Platforms
Figure 51. Natriuretic Peptide-focused Platforms
Figure 52. Other
Figure 53. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share by Cardiac Biomarker (2021-2032)
Figure 54. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Cardiac Biomarker (2021-2032)
Figure 55. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Cardiac Biomarker (2021-2032) & (US$/Unit)
Figure 56. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Application in 2025
Figure 58. Hospital
Figure 59. Clinic
Figure 60. Others
Figure 61. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Market Share by Application (2021-2032)
Figure 62. World Cardiac Biomarker POCT Immunodiagnostic Platform Production Value Market Share by Application (2021-2032)
Figure 63. World Cardiac Biomarker POCT Immunodiagnostic Platform Average Price by Application (2021-2032) & (US$/Unit)
Figure 64. Cardiac Biomarker POCT Immunodiagnostic Platform Industry Chain
Figure 65. Cardiac Biomarker POCT Immunodiagnostic Platform Procurement Model
Figure 66. Cardiac Biomarker POCT Immunodiagnostic Platform Sales Model
Figure 67. Cardiac Biomarker POCT Immunodiagnostic Platform Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
